{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:13:32Z","timestamp":1780920812629,"version":"3.54.1"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":91,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101195","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:10:47Z","timestamp":1775182247000},"page":"101195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The role of histone acetylation in mediating the anticancer effects of polyphenols: Insights from genistein, resveratrol, quercetin, curcumin, and epigallocatechin-3-gallate"],"prefix":"10.1016","volume":"47","author":[{"given":"Li","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101195_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ctarc.2026.101195_bib0002","article-title":"Adaptive mechanisms of tumor therapy resistance driven by tumor microenvironment","volume":"9","author":"Wu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178282","article-title":"Statin-mediated protection in chemotherapy-induced intestinal and cardiac toxicity: current perspectives","author":"Arendt","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0004","article-title":"Natural histone deacetylase inhibitions from legumes: exploring epigenetics modulation through systems biology","volume":"142","author":"Rizwan","year":"2025","journal-title":"Nutrition"},{"key":"10.1016\/j.ctarc.2026.101195_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70109","article-title":"The potential of resveratrol as an anticancer agent: updated overview of mechanisms, applications, and perspectives","volume":"358","author":"Islam","year":"2025","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ctarc.2026.101195_bib0006","first-page":"957","article-title":"Polyphenols bind G4-quadruplex structures and act as epigenetic modifiers with anti-cancer effects","volume":"24","author":"Meraz-Rodriguez","year":"2025","journal-title":"EXCLI. J."},{"key":"10.1016\/j.ctarc.2026.101195_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/cimb47090716","article-title":"Revisiting curcumin in cancer therapy: recent insights into molecular mechanisms, nanoformulations, and synergistic combinations","volume":"47","author":"Akter","year":"2025","journal-title":"Curr. Issues. Mol. Biol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0008","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3324\/haematol.2023.283002","article-title":"Results from a phase I trial of pembrolizumab plus vorinostat in relapsed\/refractory B-cell non-hodgkin lymphoma","volume":"109","author":"Godfrey","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.ctarc.2026.101195_bib0009","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1200\/JCO.21.01815","article-title":"Romidepsin plus CHOP versus CHOP in patients with previously untreated peripheral T-cell lymphoma: results of the Ro-CHOP Phase III study (Conducted by LYSA)","volume":"40","author":"Bachy","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-19717-w","article-title":"Adverse drug reaction profiles of histone deacetylase inhibitors","volume":"15","author":"Begum","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ctarc.2026.101195_bib0011","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.ctarc.2026.101195_bib0012","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fonc.2015.00108","article-title":"The role of histone acetyltransferases in normal and malignant hematopoiesis","volume":"5","author":"Sun","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0013","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ctarc.2026.101195_bib0014","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/157340606776056133","article-title":"Curcumin is an inhibitor of p300 histone acetylatransferase","volume":"2","author":"Marcu","year":"2006","journal-title":"Med. Chem."},{"key":"10.1016\/j.ctarc.2026.101195_bib0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1742-7843.2007.00142.x","article-title":"Curcumin, both histone deacetylase and p300\/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells","volume":"101","author":"Chen","year":"2007","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0016","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.taap.2015.12.028","article-title":"The enhancing effect of genistein on apoptosis induced by trichostatin A in lung cancer cells with wild type p53 genes is associated with upregulation of histone acetyltransferase","volume":"292","author":"Wu","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2022.106828","article-title":"CTK7A, a curcumin derivative, can be a potential candidate for targeting HIF-1\u03b1\/p300 complex: evidences from in vitro and computational studies","volume":"287","author":"Rath","year":"2022","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.ctarc.2026.101195_bib0018","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood-2015-03-632984","article-title":"Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies","volume":"126","author":"Matthews","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101195_bib0019","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1007\/s12094-022-02779-x","article-title":"Insights into the therapeutic potential of histone deacetylase inhibitor\/immunotherapy combination regimens in solid tumors","volume":"24","author":"Sedky","year":"2022","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0020","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.2174\/0929867328666210915105929","article-title":"Histone deacetylases and their inhibitors in colorectal cancer therapy: current evidence and future considerations","volume":"29","author":"Garmpis","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ctarc.2026.101195_bib0021","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ctarc.2026.101195_bib0022","article-title":"Effect of the HDAC inhibitor on histone acetylation and methyltransferases in A2780 ovarian cancer cells","volume":"57","author":"Natarajan","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ctarc.2026.101195_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612588","article-title":"Anticancer study of a novel pan-HDAC inhibitor MPT0G236 in colorectal cancer cells","volume":"24","author":"Tsai","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101195_bib0024","doi-asserted-by":"crossref","first-page":"12","DOI":"10.14715\/cmb\/2023.69.5.3","article-title":"HDAC inhibitor SB939 potentiates TRAIL-induced apoptosis in colorectal cancer cells","volume":"69","author":"Shin","year":"2023","journal-title":"Cell Mol. Biol. (Noisy-le-grand)"},{"key":"10.1016\/j.ctarc.2026.101195_bib0025","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbrc.2017.05.089","article-title":"A novel SIRT1 inhibitor, 4bb induces apoptosis in HCT116 human colon carcinoma cells partially by activating p53","volume":"488","author":"Ghosh","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ctarc.2026.101195_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114705","article-title":"Synthesis and anticancer activity of novel histone deacetylase inhibitors that inhibit autophagy and induce apoptosis","volume":"243","author":"Mo","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ctarc.2026.101195_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/srep42291","article-title":"Anti-leukemia effects of the novel synthetic 1-benzylindole derivative 21-900 in vitro and in vivo","volume":"7","author":"HuangFu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ctarc.2026.101195_bib0028","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.bbamcr.2010.01.004","article-title":"Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter","volume":"1803","author":"Lee","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ctarc.2026.101195_bib0029","first-page":"116","article-title":"Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells","volume":"55","author":"Maiti","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0030","article-title":"A novel class I HDAC inhibitor, AW01178, inhibits epithelial-mesenchymal transition and metastasis of breast cancer","volume":"25","author":"Liu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101195_bib0031","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1007\/s11033-022-07559-y","article-title":"The novel histone deacetylase inhibitor pracinostat suppresses the malignant phenotype in human glioma","volume":"49","author":"Chen","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ctarc.2026.101195_bib0032","first-page":"1159","article-title":"Epigenetic changes in histone acetylation underpin resistance to the topoisomerase I inhibitor irinotecan","volume":"45","author":"Meisenberg","year":"2017","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.ctarc.2026.101195_bib0033","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1111\/bph.14467","article-title":"Inhibition of histone deacetylase 7 reverses concentrative nucleoside transporter 2 repression in colorectal cancer by up-regulating histone acetylation state","volume":"175","author":"Ye","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0034","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.critrevonc.2017.09.004","article-title":"Genistein: its role in metabolic diseases and cancer","volume":"119","author":"Mukund","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/cpr.12022","article-title":"Genista sessilifolia DC. extracts induce apoptosis across a range of cancer cell lines","volume":"46","author":"Bontempo","year":"2013","journal-title":"Cell Prolif."},{"key":"10.1016\/j.ctarc.2026.101195_bib0036","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/ki.2008.409","article-title":"Genistein protects the kidney from cisplatin-induced injury","volume":"74","author":"Sung","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.ctarc.2026.101195_bib0037","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/mc.20300","article-title":"Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells","volume":"46","author":"Mai","year":"2007","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ctarc.2026.101195_bib0038","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1158\/0008-5472.CAN-07-2290","article-title":"Genistein induces the p21WAF1\/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification","volume":"68","author":"Majid","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101195_bib0039","article-title":"Genistein affects histone modifications on Dickkopf-related protein 1 (DKK1) gene in SW480 human colon cancer cell line","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS. One"},{"key":"10.1016\/j.ctarc.2026.101195_bib0040","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/1871520617666170918142114","article-title":"Genistein induces alterations of epigenetic modulatory signatures in Human cervical cancer cells","volume":"18","author":"Sundaram","year":"2018","journal-title":"AntiCancer Agents Med. Chem."},{"key":"10.1016\/j.ctarc.2026.101195_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113160","article-title":"Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition","volume":"416","author":"Sharma","year":"2022","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ctarc.2026.101195_bib0042","doi-asserted-by":"crossref","DOI":"10.3390\/nu9111201","article-title":"Epigenetic regulatory mechanisms induced by resveratrol","volume":"9","author":"Fernandes","year":"2017","journal-title":"Nutrients."},{"key":"10.1016\/j.ctarc.2026.101195_bib0043","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ijc.20884","article-title":"Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4\u2032-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells","volume":"115","author":"Sale","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101195_bib0044","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/biof.1544","article-title":"Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21(CIP1) in human breast cancer cell lines","volume":"45","author":"Chatterjee","year":"2019","journal-title":"Biofactors"},{"key":"10.1016\/j.ctarc.2026.101195_bib0045","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s12282-023-01465-2","article-title":"Resveratrol exhibits diverse anti-cancer activities through epigenetic regulation of E-cadherin and p21 in triple-negative breast cancer cells","volume":"30","author":"Sakamoto","year":"2023","journal-title":"Breast. Cancer"},{"key":"10.1016\/j.ctarc.2026.101195_bib0046","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12032-024-02490-7","article-title":"Polydatin inhibits histone deacetylase 1 and shows an anti-angiogenic action in head and neck squamous cell carcinoma","volume":"41","author":"Baba","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0047","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3892\/or.2017.5766","article-title":"Anticancer and apoptosis\u2011inducing effects of quercetin in vitro and in vivo","volume":"38","author":"Hashemzaei","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ctarc.2026.101195_bib0048","doi-asserted-by":"crossref","first-page":"11849","DOI":"10.1021\/acsomega.0c01818","article-title":"Therapeutic potential of quercetin: new insights and perspectives for Human health","volume":"5","author":"Salehi","year":"2020","journal-title":"ACS. Omega"},{"key":"10.1016\/j.ctarc.2026.101195_bib0049","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.biocel.2016.09.006","article-title":"Concomitant reduction of c-myc expression and PI3K\/AKT\/mTOR signaling by quercetin induces a strong cytotoxic effect against Burkitt's lymphoma","volume":"79","author":"Granato","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13148-018-0563-3","article-title":"The polyphenol quercetin induces cell death in leukemia by targeting epigenetic regulators of pro-apoptotic genes","volume":"10","author":"Alvarez","year":"2018","journal-title":"Clin. Epigenetics."},{"key":"10.1016\/j.ctarc.2026.101195_bib0051","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cbi.2019.04.006","article-title":"Quercetin enhances the antitumor activity of trichostatin A through up-regulation of p300 protein expression in p53 null cancer cells","volume":"306","author":"Chuang","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ctarc.2026.101195_bib0052","doi-asserted-by":"crossref","first-page":"11103","DOI":"10.1002\/jcp.27761","article-title":"Synergistic anticancer action of quercetin and curcumin against triple-negative breast cancer cell lines","volume":"234","author":"Kundur","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0053","doi-asserted-by":"crossref","first-page":"518","DOI":"10.14348\/molcells.2015.2339","article-title":"PLGA-loaded gold-nanoparticles precipitated with quercetin downregulate HDAC-akt activities controlling proliferation and activate p53-ROS crosstalk to induce apoptosis in hepatocarcinoma cells","volume":"38","author":"Bishayee","year":"2015","journal-title":"Mol. Cells"},{"key":"10.1016\/j.ctarc.2026.101195_bib0054","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1568009053202081","article-title":"Induction of apoptosis by curcumin and its implications for cancer therapy","volume":"5","author":"Karunagaran","year":"2005","journal-title":"Curr. Cancer Drug Targets."},{"key":"10.1016\/j.ctarc.2026.101195_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/biom11030392","article-title":"Potential role of curcumin and its nanoformulations to treat various types of cancers","volume":"11","author":"Kabir","year":"2021","journal-title":"Biomolecules."},{"key":"10.1016\/j.ctarc.2026.101195_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113956","article-title":"Curcumin: an epigenetic regulator and its application in cancer","volume":"156","author":"Ming","year":"2022","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.ctarc.2026.101195_bib0057","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jhep.2015.04.018","article-title":"Curcumin effectively inhibits oncogenic NF-\u03bab signaling and restrains stemness features in liver cancer","volume":"63","author":"Marquardt","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0058","article-title":"A novel hydroxamic acid-based curcumin derivative as potent histone deacetylase inhibitor for the treatment of glioblastoma","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0059","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17020158","article-title":"Synergistic anti-cancer activities of curcumin derivative CU17 combined with gemcitabine against A549 non-small-cell lung cancer cells","volume":"17","author":"Namwan","year":"2025","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ctarc.2026.101195_bib0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.phrs.2015.12.027","article-title":"Epigallocatechin gallate and mitochondria-A story of life and death","volume":"104","author":"Oliveira","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ctarc.2026.101195_bib0061","doi-asserted-by":"crossref","first-page":"9103","DOI":"10.1038\/s41598-021-88478-z","article-title":"(-)-Epigallocatechin-3-gallate induces apoptosis and differentiation in leukaemia by targeting reactive oxygen species and PIN1","volume":"11","author":"Della Via","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ctarc.2026.101195_bib0062","doi-asserted-by":"crossref","DOI":"10.3390\/nu8050307","article-title":"Epigallocatechin Gallate nanodelivery systems for cancer therapy","volume":"8","author":"Granja","year":"2016","journal-title":"Nutrients."},{"key":"10.1016\/j.ctarc.2026.101195_bib0063","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12032-014-0390-0","article-title":"(-)-Epigallocatechin-3-gallate induces cancer cell apoptosis via acetylation of amyloid precursor protein","volume":"32","author":"Hu","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0064","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/mc.23003","article-title":"Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes","volume":"58","author":"Deb","year":"2019","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ctarc.2026.101195_bib0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jnutbio.2016.12.015","article-title":"Down-regulation of histone deacetylase 4, -5 and -6 as a mechanism of synergistic enhancement of apoptosis in human lung cancer cells treated with the combination of a synthetic retinoid, Am80 and green tea catechin","volume":"42","author":"Oya","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ctarc.2026.101195_bib0066","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s13205-020-02473-1","article-title":"Epigallocatechin gallate inhibits HeLa cells by modulation of epigenetics and signaling pathways","volume":"10","author":"Kedhari Sundaram","year":"2020","journal-title":"3. Biotech."},{"key":"10.1016\/j.ctarc.2026.101195_bib0067","doi-asserted-by":"crossref","first-page":"51163","DOI":"10.1074\/jbc.M409024200","article-title":"Curcumin, a novel p300\/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone\/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ctarc.2026.101195_bib0068","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/1940-6207.CAPR-16-0167","article-title":"A phase II randomized, double-blind, presurgical trial of polyphenon E in bladder cancer patients to evaluate pharmacodynamics and bladder tissue biomarkers","volume":"10","author":"Gee","year":"2017","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"10.1016\/j.ctarc.2026.101195_bib0069","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1124\/dmd.104.000885","article-title":"High absorption but very low bioavailability of oral resveratrol in humans","volume":"32","author":"Walle","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ctarc.2026.101195_bib0070","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1002\/cam4.3806","article-title":"Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first-line treatment of metastatic castration-resistant prostate cancer","volume":"10","author":"Passildas-Jahanmohan","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.ctarc.2026.101195_bib0071","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1080\/10408398.2024.2328184","article-title":"EGCG-based nanoparticles: synthesis, properties, and applications","volume":"65","author":"Peng","year":"2025","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.ctarc.2026.101195_bib0072","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1124\/mol.112.079624","article-title":"Resveratrol sensitizes acute myelogenous leukemia cells to histone deacetylase inhibitors through reactive oxygen species-mediated activation of the extrinsic apoptotic pathway","volume":"82","author":"Yaseen","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0073","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061754","article-title":"The effects of combinatorial genistein and sulforaphane in breast tumor inhibition: role in epigenetic regulation","volume":"19","author":"Paul","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101195_bib0074","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00280-019-03886-3","article-title":"Genistein combined with FOLFOX or FOLFOX-Bevacizumab for the treatment of metastatic colorectal cancer: phase I\/II pilot study","volume":"84","author":"Pintova","year":"2019","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12032-022-01862-1","article-title":"A pro-oxidant combination of resveratrol and copper reduces chemotherapy-related non-haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single-arm study (RESCU III study","volume":"40","author":"Ostwal","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0076","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biocel.2019.05.020","article-title":"Resveratrol up-regulates ATP2A3 gene expression in breast cancer cell lines through epigenetic mechanisms","volume":"113","author":"Izquierdo-Torres","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0077","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/13880209.2020.1738503","article-title":"Resveratrol inhibits ACHN cells via regulation of histone acetylation","volume":"58","author":"Dai","year":"2020","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0078","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00404-021-06262-w","article-title":"The role of resveratrol, Sirtuin1 and rxr\u03b1 as prognostic markers in ovarian cancer","volume":"305","author":"Chen","year":"2022","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ctarc.2026.101195_bib0079","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.bbrc.2017.11.161","article-title":"Resveratrol strongly enhances the retinoic acid-induced superoxide generating activity via up-regulation of gp91-phox gene expression in U937 cells","volume":"495","author":"Kikuchi","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ctarc.2026.101195_bib0080","first-page":"1469","article-title":"Upregulation of PD\u2011L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3\/p300\u2011mediated NF\u2011\u03bab signaling","volume":"53","author":"Lucas","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ctarc.2026.101195_bib0081","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155057","article-title":"A novel combinatorial epigenetic therapy using resveratrol and pterostilbene for restoring estrogen receptor-\u03b1 (ER\u03b1) expression in er\u03b1-negative breast cancer cells","volume":"11","author":"Kala","year":"2016","journal-title":"PLoS. One"},{"key":"10.1016\/j.ctarc.2026.101195_bib0082","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.7314\/APJCP.2014.15.11.4539","article-title":"Aberrant epigenetic alteration in Eca9706 cells modulated by nanoliposomal quercetin combined with butyrate mediated via epigenetic-NF-\u03bab signaling","volume":"15","author":"Zheng","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ctarc.2026.101195_bib0083","article-title":"Quercetin enhances the antitumor activity of trichostatin A through upregulation of p53 protein expression in vitro and in vivo","volume":"8","author":"Chan","year":"2013","journal-title":"PLoS. One"},{"key":"10.1016\/j.ctarc.2026.101195_bib0084","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1111\/jcmm.17873","article-title":"(-)-Epigallocatechin-3-gallate induced apoptosis by dissociation of c-FLIP\/Ku70 complex in gastric cancer cells","volume":"27","author":"Shahriari Felordi","year":"2023","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ctarc.2026.101195_bib0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.yexcr.2014.01.024","article-title":"Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate","volume":"324","author":"Saldanha","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ctarc.2026.101195_bib0086","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.pan.2016.05.002","article-title":"A phase I dose escalation trial of AXP107-11, a novel multi-component crystalline form of genistein, in combination with gemcitabine in chemotherapy-naive patients with unresectable pancreatic cancer","volume":"16","author":"L\u00f6hr","year":"2016","journal-title":"Pancreatology."},{"key":"10.1016\/j.ctarc.2026.101195_bib0087","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/01635581.2021.1903949","article-title":"Randomized, placebo-controlled six-month intervention study of soy protein isolate in men with biochemical recurrence after radical prostatectomy: a pilot study","volume":"74","author":"Bosland","year":"2022","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ctarc.2026.101195_bib0088","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ijrobp.2023.08.048","article-title":"Multicenter phase 1b\/2a clinical trial of radioprotectant BIO 300 oral suspension for patients with non-small cell lung cancer receiving concurrent chemoradiotherapy","volume":"118","author":"Simone","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2026.101195_bib0089","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1039\/D0FO00565G","article-title":"Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer","volume":"11","author":"Henning","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.ctarc.2026.101195_bib0090","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125851","article-title":"Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer","volume":"4","author":"Zwicker","year":"2019","journal-title":"JCI. Insight."},{"key":"10.1016\/j.ctarc.2026.101195_bib0091","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/jn\/nxz029","article-title":"Curcumin combined with FOLFOX chemotherapy is safe and tolerable in patients with metastatic colorectal cancer in a randomized Phase IIa trial","volume":"149","author":"Howells","year":"2019","journal-title":"J. Nutr."},{"key":"10.1016\/j.ctarc.2026.101195_bib0092","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00262-022-03253-x","article-title":"Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: results of the phase II PRIMMO study","volume":"72","author":"De Jaeghere","year":"2023","journal-title":"Cancer Immunol. Immunther."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:53:58Z","timestamp":1780919638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226001061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":92,"alternative-id":["S2468294226001061"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101195","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of histone acetylation in mediating the anticancer effects of polyphenols: Insights from genistein, resveratrol, quercetin, curcumin, and epigallocatechin-3-gallate","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101195"}}